Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy.

Molecular Genetics and Metabolism
Ramin S HeratiKatherine P Ponder

Abstract

Mucopolysaccharidosis I (MPS I) and MPS VII are due to deficient activity of the glycosaminoglycan-degrading lysosomal enzymes alpha-L-iduronidase and beta-glucuronidase, respectively, and result in abnormal bones and joints. Here, the severity of skeletal disease in MPS I and MPS VII dogs and the effects of neonatal gene therapy were evaluated. For untreated MPS VII dogs, the lengths of the second cervical vertebrae (C2) and the femur were only 56% and 84% of normal, respectively, and bone dysplasia and articular erosions, and joint subluxation were severe. Previously, we reported that neonatal intravenous injection of a retroviral vector (RV) with the appropriate gene resulted in expression in liver and blood cells, and high serum enzyme activity. In this study, we demonstrate that C2 and femurs of RV-treated MPS VII dogs were longer at 82% and 101% of normal, respectively, and there were partial improvements of qualitative abnormalities. For untreated MPS I dogs, the lengths of C2 and femurs (91% and 96% of normal, respectively) were not significantly different from normal dogs. Qualitative changes in MPS I bones and joints were generally modest and were partially improved with RV treatment, although cervical spine disease w...Continue Reading

References

Mar 1, 1978·The Journal of Pediatrics·C B BrillK Hirschhorn
Feb 1, 1992·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S ByersB K Foster
Jan 1, 1989·Journal of Pediatric Orthopedics·P D PizzutilloM S Lee
Apr 1, 1989·The Journal of Clinical Investigation·E H BirkenmeierC J Wawrzyniak
May 1, 1986·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A R PooleL C Rosenberg
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·R M ShullE F Neufeld
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M S Sands, E H Birkenmeier
Jun 1, 1994·The Journal of Clinical Investigation·M S SandsE H Birkenmeier
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·M EversC Peters
Feb 15, 2001·The New England Journal of Medicine·E D KakkisE F Neufeld
Mar 23, 2002·The Journal of Biological Chemistry·Prasanthi GovindrajJohn R Hassell
Feb 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro OhmiElizabeth F Neufeld
Dec 9, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuli LiuKatherine Parker Ponder
Oct 3, 2006·Molecular Genetics and Metabolism·Monica SifuentesEmil D Kakkis
May 24, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anne M TraasKatherine P Ponder
Sep 19, 2007·Journal of Inherited Metabolic Disease·A R GarciaJ Muenzer

❮ Previous
Next ❯

Citations

Mar 19, 2009·ILAR Journal·Christine Gagliardi, Bruce A Bunnell
Oct 22, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jason A MetcalfKatherine P Ponder
Dec 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gabriella CotugnoAlberto Auricchio
Mar 8, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katherine P PonderMark E Haskins
Jan 11, 2012·Rheumatology·Vassili Valayannopoulos, Frits A Wijburg
Dec 30, 2014·Molecular Genetics and Metabolism·Shunji TomatsuTadao Orii
Jan 7, 2015·Molecular Genetics and Metabolism·Elizabeth M XingKatherine P Ponder
Apr 25, 2012·Molecular Genetics and Metabolism·Carmen E MacsaiSharon Byers
Nov 18, 2009·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Lachlan J SmithDawn M Elliott
Jun 6, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Joseph A ChiaroLachlan J Smith
Apr 19, 2012·Molecular Genetics and Metabolism·Lachlan J SmithKatherine P Ponder
Apr 20, 2012·Molecular Genetics and Metabolism·Lachlan J SmithKatherine P Ponder
May 1, 2013·Molecular Genetics and Metabolism·Elizabeth M XingKatherine P Ponder
May 20, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Lorne A Clarke, Carla E M Hollak
Feb 12, 2015·Human Gene Therapy. Clinical Development·Allison M BradburyMark E Haskins
Aug 20, 2014·Skeletal Radiology·Arpita Rai ThakurAtul Sattur
Oct 27, 2016·Molecular Genetics and Metabolism·Ainslie L K Derrick-RobertsSharon Byers
Sep 19, 2008·Journal of Neuropathology and Experimental Neurology·Raquel M WaltonJohn H Wolfe
Nov 25, 2014·Expert Opinion on Orphan Drugs·Shunji TomatsuTadao Orii
Nov 19, 2015·Journal of Inherited Metabolic Disease·Shunji TomatsuMarta Serafini
Jun 23, 2021·Molecular Genetics and Metabolism·Sun H PeckLachlan J Smith
Oct 17, 2020·Current Osteoporosis Reports·Zhirui JiangLachlan J Smith
Sep 5, 2021·Journal of Inherited Metabolic Disease·Sandra D K Kingma, An I Jonckheere

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.